Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Jelly in Urodynamics (LULU)
NCT04038099Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine 10% oropharyngeal spray in urinary incontinence (UI), pelvic organ prolapse (POP), pelvic floor disorders (PFDs), sponsored by UT Southwestern Medical Center. Started Aug 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
urinary incontinence (UI)pelvic organ prolapse (POP)pelvic floor disorders (PFDs)
Beyond the preview
Go deeper on NCT04038099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04038099.